SGP
SGP Articles
Usually drug companies look forward to presenting data on their drugs and medical treatments. The the American College of Cardiology meeting was this weekend, and the findings and recommendations...
Published:
These are not all of the calls we are seeing this morning, but these are the top analyst calls we see affecting shares in pre-market trading this Monday morning: GFI Group (NASDAQ: GFIG) started as...
Published:
According to Reuters, the Treasury Department will announce a proposed major overhaul of the US financial regulatory system. Reuters writes that Yahoo! (YHOO) introduced Shine, a site for women....
Published:
Below are the top analyst calls that a673b.bigscoots-temp.com is looking at this morning: Capella Education (NASDAQ: CPLA) started as Neutral at JPMorgan. Cephalon (NASDAQ: CEPH) raised to Strong Buy at...
Published:
Schering-Plough Corp. (NYSE: SGP) is probably breathing a sigh of relief this morning after Merck’s earnings as it is partners with the drug giant on Vytorin and Zetia for cholesterol treatments....
Published:
According to Reuters, gaps in controls at Societe Generale allowed a junior trader to make at $73 billion losing bet on European shares prices. Reuters writes that Countrywide’s (CFC) CEO will give...
Published:
Once Eliot Spitzer left his office as prosecutor to become governor of New York State many feared that there would be no one left to devil large corporations and Wall St. firms. The fears were...
Published:
If analysts were cowboys they’d say, "It’s getting pretty darn thin out there on the research front." Here are the few analyst calls we are looking at today ahead of what most of Wall Street...
Published:
Last Updated:
Aetna (AET) raised to Overweight at JPMorgan.Bankrate (RATE) raised to Outperform at Bear Stearns.Celgene (CELG) raised to Buy at Banc of America.Deere (DE) raised to Buy at Banc of America.Fannie...
Published:
Last Updated:
Novacea, Inc. (NASDAQ:NOVC) has ended its Phase III ASCENT-2 clinical trial of Asentar(TM) (DN-101). Unfortunately this is Novacea’s lead investigational cancer therapy for the treatment of...
Published:
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but its short...
Published:
Stock Tickers: MRK, PFE, JNJ, GSK, SGP, LLY, WYE, NVS, NVO On tonight’s MAD MONEY on CNBC, Jim Cramer said he keeps getting asked about Big Pharma drug stocks. He’d rather focus on farms, but...
Published:
This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. Cancer stocks in the last few weeks have been seeing a muted response...
Published:
Novacea (NOVC-NASDAQ) is seeing its shares up more than 70% after signing a pact with Schering-Plough (SGP-NYSE) over the development and commercialization of Asentar for the treatment of prostate...
Published:
Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April. Below is the...
Published: